Amygdala abnormalities in first-degree relatives of individuals with schizophrenia unmasked by benzodiazepine challenge

Psychopharmacology

Volumn 218, Issue 3, 2011, Pages 503-512

  Wolf, Daniel H ^a   Satterthwaite, Theodore D ^a   Loughead, James ^a   Pinkham, Amy ^d   Overton, Eve ^a   Elliott, Mark A ^a   Dent, Gersham W ^c   Smith, Mark A ^c   Gur, Ruben C ^a,b   Gur, Raquel E ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c ASTRAZENECA   (United Kingdom)

^d SOUTHERN METHODIST UNIVERSITY   (United States)

Author keywords

Amygdala; Benzodiazepine; Endophenotype; Facial emotion; GABA; Pharmacological fMRI; Schizophrenia

Indexed keywords

ALPRAZOLAM;

ADULT; AMYGDALOID NUCLEUS; ARTICLE; CONTROLLED STUDY; EMOTION; FAMILY HISTORY; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GABAERGIC SYSTEM; HIPPOCAMPUS; HUMAN; HUMAN EXPERIMENT; MALE; MEMORY; NEUROMODULATION; NORMAL HUMAN; PHARMACOLOGICAL PROCEDURES; PRIORITY JOURNAL; RELATIVE; SCHIZOPHRENIA;

ADULT; ALPRAZOLAM; AMYGDALA; ANTI-ANXIETY AGENTS; CASE-CONTROL STUDIES; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; EMOTIONS; FAMILY; FEMALE; GAMMA-AMINOBUTYRIC ACID; HIPPOCAMPUS; HUMANS; MALE; MEMORY; MIDDLE AGED; SCHIZOPHRENIA; YOUNG ADULT;

EID: 82955203840     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-011-2348-7     Document Type: Article

References (49)

1. J Addington H Saeedi D Addington 2006 Facial affect recognition: a mediator between cognitive and social functioning in psychosis? Schizophr Res 85 142 150 16678388 10.1016/j.schres.2006.03.028 (Pubitemid 43947538)
2. Anticevic A, Van Snellenberg JX, Cohen RE, Repovs G, Dowd EC, Barch DM (2010) Amygdala recruitment in schizophrenia in response to aversive emotional material: a meta-analysis of neuroimaging studies. Schizophr Bull. doi: 10.1093/schbul/sbq131
3. E Arce AN Simmons KL Lovero MB Stein MP Paulus 2008 Escitalopram effects on insula and amygdala BOLD activation during emotional processing Psychopharmacology (Berl) 196 661 672 10.1007/s00213-007-1004-8 1:CAS:528:DC%2BD1cXhvFykurw%3D
4. JG Barbee FW Black AA Todorov 1992 Differential effects of alprazolam and buspirone upon acquisition, retention, and retrieval processes in memory J Neuropsychiatry Clin Neurosci 4 308 314 1498583 1:STN:280:DyaK38zmtFWqsg%3D%3D
5. G Bedi KL Phan M Angstadt H de Wit 2009 Effects of MDMA on sociability and neural response to social threat and social reward Psychopharmacology (Berl) 207 73 83 10.1007/s00213-009-1635-z 1:CAS:528:DC%2BD1MXpvV2ntbc%3D
6. S Berretta DW Munno FM Benes 2001 Amygdalar activation alters the hippocampal GABA system: "partial" modelling for postmortem changes in schizophrenia J Comp Neurol 431 129 138 11169995 10.1002/1096-9861(20010305) 431:2<129::AID-CNE1060>3.0.CO;2-6 1:STN:280:DC%2BD3M3isVyrsg%3D%3D (Pubitemid 32118649)
7. TW Buchanan MS Karafin R Adolphs 2003 Selective effects of triazolam on memory for emotional, relative to neutral, stimuli: differential effects on gist versus detail Behav Neurosci 117 517 525 12802880 10.1037/0735-7044.117.3.517 1:CAS:528:DC%2BD3sXkvFGks7c%3D (Pubitemid 36686969)
8. CS Carter DM Barch R Gur A Pinkham K Ochsner 2009 CNTRICS final task selection: social cognitive and affective neuroscience-based measures Schizophr Bull 35 153 162 19011231 10.1093/schbul/sbn157
9. NJ Coupland AJ Singh RA Sustrik P Ting R Blair 2003 Effects of diazepam on facial emotion recognition J Psychiatry Neurosci 28 452 463 14631456 (Pubitemid 38091174)
10. AM Dale 1999 Optimal experimental design for event-related fMRI Hum Brain Mapp 8 109 114 10524601 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID- HBM7>3.0.CO;2-W 1:STN:280:DyaK1Mvlt1agsA%3D%3D (Pubitemid 29480297)
11. M Davis 1992 The role of the amygdala in fear and anxiety Annu Rev Neurosci 15 353 375 1575447 10.1146/annurev.ne.15.030192.002033 1:STN:280:DyaK383ks1Cmsw%3D%3D
12. Del-Ben CM, Ferreira CA, Sanchez TA, Alves-Neto WC, Guapo VG, de Araujo DB, Graeff FG (2010) Effects of diazepam on BOLD activation during the processing of aversive faces. J Psychopharmacol. doi: 10.1177/0269881110389092
13. DJ Greenblatt JS Harmatz C Dorsey RI Shader 1988 Comparative single-dose kinetics and dynamics of lorazepam, alprazolam, prazepam, and placebo Clin Pharmacol Ther 44 326 334 3138056 10.1038/clpt.1988.158 1:CAS:528: DyaL1cXlvVaqu7s%3D
14. RC Gur R Sara M Hagendoorn O Marom P Hughett L Macy T Turner R Bajcsy A Posner RE Gur 2002 A method for obtaining 3-dimensional facial expressions and its standardization for use in neurocognitive studies J Neurosci Methods 115 137 143 11992665 10.1016/S0165-0270(02)00006-7 (Pubitemid 34461962)
15. RE Gur J Loughead CG Kohler MA Elliott K Lesko K Ruparel DH Wolf WB Bilker RC Gur 2007 Limbic activation associated with misidentification of fearful faces and flat affect in schizophrenia Arch Gen Psychiatry 64 1356 1366 18056543 10.1001/archpsyc.64.12.1356 (Pubitemid 350223553)
16. RE Gur VL Nimgaonkar L Almasy ME Calkins JD Ragland MF Pogue-Geile S Kanes J Blangero RC Gur 2007 Neurocognitive endophenotypes in a multiplex multigenerational family study of schizophrenia Am J Psychiatry 164 813 819 17475741 10.1176/appi.ajp.164.5.813 (Pubitemid 46808537)
17. U Habel M Klein NJ Shah I Toni K Zilles P Falkai F Schneider 2004 Genetic load on amygdala hypofunction during sadness in nonaffected brothers of schizophrenia patients Am J Psychiatry 161 1806 1813 15465977 10.1176/appi.ajp.161.10.1806 (Pubitemid 39314674)
18. J Hall HC Whalley JW McKirdy R Sprengelmeyer IM Santos DI Donaldson DJ McGonigle AW Young AM McIntosh EC Johnstone SM Lawrie 2009 A common neural system mediating two different forms of social judgement Psychol Med 40 1183 1192 19811702 10.1017/S0033291709991395
19. CJ Harmer CE Mackay CB Reid PJ Cowen GM Goodwin 2006 Antidepressant drug treatment modifies the neural processing of nonconscious threat cues Biol Psychiatry 59 816 820 16460693 10.1016/j.biopsych.2005.10.015 1:CAS:528:DC%2BD28XjsFOnt7w%3D
20. T Hashimoto HH Bazmi K Mirnics Q Wu AR Sampson DA Lewis 2008 Conserved regional patterns of GABA-related transcript expression in the neocortex of subjects with schizophrenia Am J Psychiatry 165 479 489 18281411 10.1176/appi.ajp.2007.07081223 (Pubitemid 351694291)
21. C Heimberg RE Gur RJ Erwin DL Shtasel RC Gur 1992 Facial emotion discrimination: III. Behavioral findings in schizophrenia Psychiatry Res 42 253 265 1496057 10.1016/0165-1781(92)90117-L 1:STN:280:DyaK38zlslymsA%3D%3D
22. DJ Holt L Kunkel AP Weiss DC Goff CI Wright LM Shin SL Rauch J Hootnick S Heckers 2006 Increased medial temporal lobe activation during the passive viewing of emotional and neutral facial expressions in schizophrenia Schizophr Res 82 153 162 16377154 10.1016/j.schres.2005.09.021 (Pubitemid 43290679)
23. CG Kohler JB Walker EA Martin KM Healey PJ Moberg 2009 Facial emotion perception in schizophrenia: a meta-analytic review Schizophr Bull 36 1009 1019 19329561 10.1093/schbul/sbn192
24. DA Lewis T Hashimoto DW Volk 2005 Cortical inhibitory neurons and schizophrenia Nat Rev Neurosci 6 312 324 15803162 10.1038/nrn1648 1:CAS:528:DC%2BD2MXivVarsbc%3D (Pubitemid 40469985)
25. DA Lewis RY Cho CS Carter K Eklund S Forster MA Kelly D Montrose 2008 Subunit-selective modulation of GABA type A receptor neurotransmission and cognition in schizophrenia Am J Psychiatry 165 1585 1593 18923067 10.1176/appi.ajp.2008.08030395
26. H Li RC Chan GM McAlonan QY Gong 2009 Facial emotion processing in schizophrenia: a meta-analysis of functional neuroimaging data Schizophr Bull 36 1029 1039 19336391 10.1093/schbul/sbn190
27. AW MacDonald 3rd HW Thermenos DM Barch LJ Seidman 2009 Imaging genetic liability to schizophrenia: systematic review of FMRI studies of patients' nonpsychotic relatives Schizophr Bull 35 1142 1162 18556667 10.1093/schbul/ sbn053
28. L Menzies C Ooi S Kamath J Suckling P McKenna P Fletcher E Bullmore C Stephenson 2007 Effects of gamma-aminobutyric acid-modulating drugs on working memory and brain function in patients with schizophrenia Arch Gen Psychiatry 64 156 167 17283283 10.1001/archpsyc.64.2.156 1:CAS:528:DC%2BD2sXisFylsLk%3D (Pubitemid 46220773)
29. MB Meyer MM Kurtz 2009 Elementary neurocognitive function, facial affect recognition and social-skills in schizophrenia Schizophr Res 110 173 179 19328653 10.1016/j.schres.2009.03.015
30. MG Monteiro MA Schuckit M Irwin 1990 Subjective feelings of anxiety in young men after ethanol and diazepam infusions J Clin Psychiatry 51 12 16 2295585 1:STN:280:DyaK3c7gvF2ruw%3D%3D (Pubitemid 20042561)
31. MP Paulus JS Feinstein G Castillo AN Simmons MB Stein 2005 Dose-dependent decrease of activation in bilateral amygdala and insula by lorazepam during emotion processing Arch Gen Psychiatry 62 282 288 15753241 10.1001/archpsyc.62. 3.282 1:CAS:528:DC%2BD2MXislOisbs%3D (Pubitemid 40990973)
32. RH Perlis M Ostacher M Fava AA Nierenberg GS Sachs JF Rosenbaum 2010 Assuring that double-blind is blind Am J Psychiatry 167 250 252 20194487 10.1176/appi.ajp.2009.09060820
33. KL Phan M Angstadt J Golden I Onyewuenyi A Popovska H de Wit 2008 Cannabinoid modulation of amygdala reactivity to social signals of threat in humans J Neurosci 28 2313 2319 18322078 10.1523/JNEUROSCI.5603-07.2008 1:CAS:528:DC%2BD1cXjt1GhtLg%3D (Pubitemid 351348194)
34. LK Phillips LJ Seidman 2008 Emotion processing in persons at risk for schizophrenia Schizophr Bull 34 888 903 18644853 10.1093/schbul/sbn085
35. B Rasch A Papassotiropoulos DF de Quervain 2010 Imaging genetics of cognitive functions: focus on episodic memory Neuroimage 53 870 877 20060913 10.1016/j.neuroimage.2010.01.001 1:STN:280:DC%2BC3cfgsVChtA%3D%3D
36. R Rasetti VS Mattay LM Wiedholz BS Kolachana AR Hariri JH Callicott A Meyer-Lindenberg DR Weinberger 2009 Evidence that altered amygdala activity in schizophrenia is related to clinical state and not genetic risk Am J Psychiatry 166 216 225 19074979 10.1176/appi.ajp.2008.08020261
37. P Roy-Byrne J Fleishaker C Arnett M Dubach J Stewart A Radant R Veith M Graham 1993 Effects of acute and chronic alprazolam treatment on cerebral blood flow, memory, sedation, and plasma catecholamines Neuropsychopharmacology 8 161 169 8471128 1:CAS:528:DyaK3sXkt1Sgs7o%3D (Pubitemid 23051864)
38. TD Satterthwaite DH Wolf J Loughead K Ruparel JN Valdez SJ Siegel CG Kohler RE Gur RC Gur 2010 Association of enhanced limbic response to threat with decreased cortical facial recognition memory response in schizophrenia Am J Psychiatry 167 418 426 20194482 10.1176/appi.ajp.2009.09060808
39. F Schneider U Habel M Reske I Toni P Falkai NJ Shah 2007 Neural substrates of olfactory processing in schizophrenia patients and their healthy relatives Psychiatry Res 155 103 112 17532193 10.1016/j.pscychresns.2006.12.004 (Pubitemid 46874911)
40. T Schunck A Mathis G Erb IJ Namer A Demazieres R Luthringer 2010 Effects of lorazepam on brain activity pattern during an anxiety symptom provocation challenge J Psychopharmacol 24 701 708 19460871 10.1177/0269881109104864 1:CAS:528:DC%2BC3cXot1Kgs78%3D
41. MD Simpson P Slater JF Deakin MC Royston WJ Skan 1989 Reduced GABA uptake sites in the temporal lobe in schizophrenia Neurosci Lett 107 211 215 2616032 10.1016/0304-3940(89)90819-7 1:STN:280:DyaK3c7jslCntA%3D%3D
42. EG Spokes NJ Garrett MN Rossor LL Iversen 1980 Distribution of GABA in post-mortem brain tissue from control, psychotic and Huntington's chorea subjects J Neurol Sci 48 303 313 6449563 10.1016/0022-510X(80)90103-3 1:STN:280:DyaL3M%2FntFentw%3D%3D (Pubitemid 11216871)
43. CC Streeter DA Ciraulo GJ Harris MJ Kaufman RF Lewis CM Knapp AM Ciraulo LC Maas M Ungeheuer S Szulewski PF Renshaw 1998 Functional magnetic resonance imaging of alprazolam-induced changes in humans with familial alcoholism Psychiatry Res 82 69 82 9754450 10.1016/S0925-4927(98)00009-2 1:CAS:528:DyaK1cXlsVOgsL0%3D (Pubitemid 28341668)
44. ND Volkow GJ Wang R Hitzemann JS Fowler N Pappas P Lowrimore G Burr K Pascani J Overall AP Wolf 1995 Depression of thalamic metabolism by lorazepam is associated with sleepiness Neuropsychopharmacology 12 123 132 7779240 10.1016/0893-133X(94)00068-B 1:CAS:528:DyaK2MXlsVektLg%3D
45. Z Wang GK Aguirre H Rao J Wang MA Fernandez-Seara AR Childress JA Detre 2008 Empirical optimization of ASL data analysis using an ASL data processing toolbox: ASLtbx Magn Reson Imaging 26 261 269 17826940 10.1016/j.mri.2007.07.003
46. C Windischberger R Lanzenberger A Holik C Spindelegger P Stein U Moser F Gerstl M Fink E Moser S Kasper 2010 Area-specific modulation of neural activation comparing escitalopram and citalopram revealed by pharmaco-fMRI: a randomized cross-over study Neuroimage 49 1161 1170 19833214 10.1016/j.neuroimage.2009.10.013 1:CAS:528:DC%2BC3cXltFGgsL8%3D
47. RG Wise I Tracey 2006 The role of fMRI in drug discovery J Magn Reson Imaging 23 862 876 16649197 10.1002/jmri.20584 (Pubitemid 43825441)
48. MW Woolrich BD Ripley M Brady SM Smith 2001 Temporal autocorrelation in univariate linear modeling of FMRI data Neuroimage 14 1370 1386 11707093 10.1006/nimg.2001.0931 1:STN:280:DC%2BD3MnlsVyjtg%3D%3D (Pubitemid 33124185)
49. MW Woolrich TE Behrens CF Beckmann M Jenkinson SM Smith 2004 Multilevel linear modelling for FMRI group analysis using Bayesian inference Neuroimage 21 1732 1747 15050594 10.1016/j.neuroimage.2003.12.023 (Pubitemid 38446594)